Jacobs Levy Equity Management’s Evolent Health EVH Stock Holding History

Jacobs Levy Equity Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.68M	Buy	1,601,638 +991,536	+163%	+$3.8M	0.03%	338
2026 Q1	$1.39M	Sell	610,102 -1,658,770	-73%	-$5.26M	0.01%	652
2025 Q4	$9.08M	Buy	2,268,872 +495,054	+28%	+$2.75M	0.04%	317
2025 Q3	$15M	Buy	1,773,818 +1,102,264	+164%	+$10.7M	0.06%	243
2025 Q2	$7.56M	Buy	+671,554	New	+$6.17M	0.03%	348
2023 Q1	–	Sell	-26,310	Closed	-$739K	–	997
2022 Q4	$739K	Sell	26,310 -202,145	-88%	-$5.79M	0.01%	726
2022 Q3	$8.21M	Buy	+228,455	New	+$8.05M	0.06%	296
2020 Q2	–	Sell	-90,800	Closed	-$493K	–	1067
2020 Q1	$493K	Buy	+90,800	New	+$811K	0.01%	756

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jacobs Levy Equity Management's EVH Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Evolent Health (EVH) stake by 163% in Q2 2026, buying an estimated $3.8M and bringing the position to 1,601,638 shares worth $8.68M. The position accounts for 0.03% of the portfolio, ranked #338.

Jacobs Levy Equity Management first reported a position in EVH in Q1 2020 and has held it in 8 quarters since. The position peaked at $15M in Q3 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Jacobs Levy Equity Management held 1,601,638 shares of Evolent Health worth $8.68M as of Q2 2026.
Jacobs Levy Equity Management bought 991,536 Evolent Health shares in Q2 2026, an estimated $3.8M.
Evolent Health made up 0.03% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #338 holding.
Jacobs Levy Equity Management first reported a position in Evolent Health in Q1 2020 and has held it in 8 quarters since.
Jacobs Levy Equity Management's Evolent Health position peaked at $15M in Q3 2025.
199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.